Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 07-2005 | 06-2005 | 04-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -610 | -610 | -2,670 | N/A | -1,960 |
| Depreciation Amortization | 60 | 60 | 260 | N/A | 180 |
| Accounts receivable | N/A | 0 | N/A | 41 | N/A |
| Other Working Capital | -150 | -150 | 60 | N/A | 80 |
| Other Operating Activity | -40 | -40 | 360 | -41 | 310 |
| Operating Cash Flow | $-740 | $-740 | $-1,990 | $N/A | $-1,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | -70 | N/A | -70 |
| Purchase Sale Intangibles | N/A | 0 | N/A | -37 | N/A |
| Other Investing Activity | -5 | -5 | -30 | 0 | -30 |
| Investing Cash Flow | $-10 | $-10 | $-100 | $N/A | $-100 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 0 | N/A | 2,385 | N/A |
| Other Financing Activity | 1,450 | 1,450 | 2,380 | -2,385 | 2,240 |
| Financing Cash Flow | $1,450 | $1,450 | $2,380 | $N/A | $2,240 |
| Beginning Cash Position | 580 | 580 | 300 | N/A | 300 |
| End Cash Position | 1,280 | 1,280 | 580 | N/A | 1,050 |
| Net Cash Flow | $690 | $690 | $280 | $N/A | $740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -740 | -740 | -1,990 | N/A | -1,390 |
| Capital Expenditure | N/A | 0 | N/A | -70 | N/A |
| Free Cash Flow | -740 | -740 | -1,990 | -70 | -1,390 |